(1)
Preclinical Evaluation of the Innovative MK-7 NE: Toxicity Assessment and Safety Optimization in In Vivo Models. Int. J. Pharm. Sci. Drug Res. 2025, 17 (3), 216-226. https://doi.org/10.25004/IJPSDR.2025.170301.